Mitral regurgitation sheds light on TAVR prognosis, data show

10/14/2013 | TCTMD.com

Patients who underwent transcatheter aortic valve replacement had a worse prognosis if they experienced moderate or severe mitral regurgitation, according to an evaluation of 1,007 MR patients who received TAVR treatment for severe aortic stenosis. "I still make the presumption that these patients got something out of TAVR, but that MR has a graded [adverse] effect on late outcomes," said SCAI fellow Dr. Ted Feldman. "For me, the utility of this paper is in managing patient expectations."

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC